コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 (111)In-octreotide it was 78.2%; specificity was not available).
2 exception of families in which DNA analysis was not available).
3 y as an alternative, especially when bismuth is not available.
4 ce in countries where the reverse cold chain is not available.
5 reening tool for ALVD in the doctor's office is not available.
6 l survival following DSB induction when H2AX is not available.
7 e, being a key indicator of reproducibility, is not available.
8 n PCR is delayed, shows negative results, or is not available.
9 Effective chemotherapy is not available.
10 surrogate tumor biopsy when Rb tumor tissue is not available.
11 whom hematopoietic stem cell transplantation is not available.
12 l studies, for most of them this information is not available.
13 ng a working diagnosis of IPF if lung tissue is not available.
14 vaccine to prevent C. trachomatis infections is not available.
15 ture decision making when immediate feedback is not available.
16 ubcortical pathways when PER-POR interaction is not available.
17 ify candidates appropriate for PPI cessation is not available.
18 address, especially if the protein structure is not available.
19 and easy scheme for their in vitro synthesis is not available.
20 re a good alternative when higher resolution is not available.
21 tested for CJD, in part because an easy test is not available.
22 t the gene expression profile of these cells is not available.
23 ucture for conventional wastewater treatment is not available.
24 st useful when a suitable structure template is not available.
25 but the relevant information in avian brain is not available.
26 a structural basis for their mode of action is not available.
27 ommunity level where laboratory confirmation is not available.
28 tive, especially when hybrid (123)I SPECT/CT is not available.
29 a reliable animal model of such TMJ diseases is not available.
30 l congestion, and site-selective information is not available.
31 omplete profiles for which experimental data is not available.
32 deaths in children worldwide, and a vaccine is not available.
33 energy expenditure when indirect calorimetry is not available.
34 ospitalization and death after HHC discharge is not available.
35 genome-wide evaluation of these predictions is not available.
36 for different brain lesions causing epilepsy is not available.
37 ic scintigraphy, especially when PET imaging is not available.
38 n of the functional features of fusion genes is not available.
39 en for which a commercial vaccine for humans is not available.
40 r the study of interplay of these mechanisms is not available.
41 tries, or when information on all predictors is not available.
42 e-income countries where surgical management is not available.
43 utationally involved since phase information is not available.
44 An effective EBV vaccine is not available.
45 hondrial homeostasis in APTX-deficient cells is not available.
46 rsistent tags working in bright environments are not available.
47 are limited and curative treatment regimens are not available.
48 tic matrices for external calibration curves are not available.
49 ally, yet Salmonella-specific antibacterials are not available.
50 n >=190 mg/dl), overall prevalence estimates are not available.
51 with metastatic renal cell carcinoma (mRCC) are not available.
52 pseudo-replicates when technical replicates are not available.
53 pped exon units in cancer and normal tissues are not available.
54 ood and nesting resources when apple flowers are not available.
55 ion and policy efforts where biological data are not available.
56 val data with direct-acting antiviral agents are not available.
57 g domains for which ready-made formal models are not available.
58 remia (SaB) animal models, but clinical data are not available.
59 and rural areas in China during this period are not available.
60 ated toxicants and carcinogens in wastewater are not available.
61 s to mitigate the adverse effects of drought are not available.
62 icensed vaccines or suitable antiviral drugs are not available.
63 cases, especially when skilled microscopists are not available.
64 Up to now, approved treatment options are not available.
65 noninvasive biomarkers for PSC, CCA, and HCC are not available.
66 especially where electronic medical records are not available.
67 ons, especially when high-quality antibodies are not available.
68 ll poorly understood and targeted treatments are not available.
69 hylation calling method when normal controls are not available.
70 mes for metazoa that undergo DNA elimination are not available.
71 ls for semi-automated variant interpretation are not available.
72 PLATZER Septal Occluder in clinical practice are not available.
73 xpert opinion because rigorous clinical data are not available.
74 here whole-slide scanning microscopy systems are not available.
75 ation is viable when biomonitoring organisms are not available.
76 ting N sources in the residential catchments are not available.
77 ften restricted because fresh-frozen tissues are not available.
78 e) when glucose and other fermentable sugars are not available.
79 ical agents that directly target mutant KRAS are not available.
80 single individual when mates or pollinators are not available.
81 t fully understood; specific anti-HPV agents are not available.
82 s due to growth faltering in early childhood are not available.
83 which preventative or therapeutic strategies are not available.
84 ies that prevent or alleviate this condition are not available.
85 g criteria, and specific biochemical markers are not available.
86 es, but data from randomized clinical trials are not available.
87 aining in lieu of direct observations, which are not available.
88 required by international law, they commonly are not available.
89 the selection of ISs whenever matching SILs are not available.
90 consuming lizard eggs when green turtle eggs are not available.
91 instrumental evaluations of GERD after LRYGB are not available.
92 ons where relevant experimental measurements are not available.
93 uding complexes for which crystal structures are not available.
94 with sickle cell disease, but accurate data are not available.
95 ountries where newer, expensive combinations are not available.
96 uidelines based on patient-reported outcomes are not available.
97 injury (AKI), targeted preventive strategies are not available.
98 d structures of filament-associated troponin are not available.
99 -likelihood evaluation when exact techniques are not available.
100 effective treatment and prevention measures are not available.
101 and additional vessels from the organ donor are not available.
102 tablet regimens, but long-term outcomes data are not available.
103 medical treatments for infected individuals are not available.
104 urthermore, human B. bronchiseptica vaccines are not available.
105 standard Digene Hybrid Capture 2 (HC2) test are not available.
106 erroneously estimated if strand information was not available.
107 rends, SLE disease activity, and medications was not available.
108 Information on the severity of CP was not available.
109 ables included in the risk prediction models was not available.
110 t in the blood pool; histologic confirmation was not available.
111 ch were conducted at a time when ranibizumab was not available.
112 rmed to include data from RCTs for which IPD was not available.
113 l donors if donation after circulatory death was not available.
114 was determined by PCR, or microscopy if PCR was not available.
115 In 4 patients the SMN2 copy number was not available.
116 direct feedback from participating hospitals was not available.
117 ence early in the season when coupled models were not available.
118 Age-specific data for some harms were not available.
119 fact that physiologically relevant tubulins were not available.
120 ties where blood pressure-lowering medicines were not available.
121 p; data for peak expiratory flow variability were not available.
122 l inputs because individual-participant data were not available.
123 e data required to fully test the hypothesis were not available.
124 cluded only for interventions for which RCTs were not available.
125 d in one country endomysial antibodies (EMA) were not available.
126 5 and 2 degrees C above preindustrial levels were not available.
127 ators of studies for which the required data were not available.
128 antibody test result if HCV RNA measurements were not available.
129 Drug data for treatment of depression were not available.
130 e-out diagnosis, and a management plan if CT were not available.
131 omparison group and longitudinal assessments were not available.
132 antibody test result if HCV RNA measurements were not available.
133 primary analyses because patient-level data were not available.
134 Data on postnatal factors were not available.
135 Data on falls and syncope were not available.
136 was relatively brief, and patient-level data were not available.
137 HLA-matched donors, but when a matched donor is not available, a haploidentical or mismatched unrelat
138 accination or laboratory-confirmed infection is not available, Advisory Committee on Immunization Pra
139 methods for use when cell-type specific DMRs are not available, allowing scientists to estimate putat
140 miologic toolbox in cases in which real data are not available and in cases in which traditional epid
141 Commercial inhibitors for HtrA proteases are not available and physiologic HtrA inhibitors are un
142 sed in recent years, but prospective studies are not available and the complication profile is poorly
143 on the chemo-resistivity of the cancer cells is not available and it currently takes weeks to months
144 MICs where integrated multidisciplinary care is not available and resources are lacking at present.
145 compounds experimentally determined L-values were not available and had to be measured using gas chro
146 ting where original individual-level records are not available, and employs a covariance shrinkage al
147 ameters, but alternative approved treatments are not available, and in the case of HMA failure, there
148 ts, but their potent and specific inhibitors are not available, and strategies for inhibitor developm
149 ted models to predict risk for complications are not available, and the effect of treatment on risk i
150 tood because selective high affinity ligands are not available, and the threshold for heat activation
152 plasma glucose level and HbA1c concentration were not available, and the glycemic control status was
153 ine against the parasite that causes malaria is not available, antimalarial drug treatments are criti
156 using spatial light modulators, such methods are not available at all lengthscales and wavelengths of
157 ntibody test results and response to therapy are not available at disease onset, we based the initial
165 ing clues from the literature, many of which were not available at the time that the mysteries emerge
168 ysical data containing structural restraints are not available, but one still wants to obtain knowled
172 lind, placebo-controlled food challenge data are not available, data from widely used open food chall
173 al principles of thermodynamics and kinetics are not available, despite the critical role that such p
174 disorders associated with de novo mutations is not available, despite their relatively high incidenc
175 nti-fibrotic therapeutic solutions, however, are not available due to the poorly defined characterist
176 mation on the internal OC exposure in humans is not available, due to the lack of appropriate biomark
177 n thin ice films, providing a mechanism that is not available during the growth of strained films in
178 mula (control, n = 117) whenever breast milk was not available during the first 6-8 months of life.
182 d nanoscale MOFs, rapid and flexible methods are not available for continuous, one-pot synthesis and
184 ong participants, and that longitudinal data are not available for long-term follow-up of individuals
190 thod of choice; however, these genetic tools are not available for most organisms and alternative lab
192 ely heavily on uniquely mapping reads, which are not available for numerous isoforms that lack region
203 ed WCR diets contain corn root powder, which is not available for purchase, thereby limiting the prac
210 In a complete-case analysis in which data were not available for 23 patients in the intervention g
214 ality, and current disease severity criteria were not available for patients in the 2003-to-2007 coho
217 ated genes and swine virus genomic sequences are not available from the exposure source, future cases
218 ut the rate of future cognitive decline that is not available from a dichotomous positive/negative ca
219 ire complex and contraction mechanism, which is not available from baseplate structures of the (DNA-c
221 avicular line; and if a baseline measurement is not available, hepatomegaly can be defined as greater
223 defined and unique loci of the yeast genome are not available, hindering studies of DSB repair in di
226 earch, particularly where clinical specimens are not available in amounts amenable to standard workfl
232 curate when expression data for causal genes are not available in the causal tissue by leveraging exp
234 ORBED and the resulting reducing equivalents are not available in the outermost few nanometers of cla
238 crystal structure of full-length BM3 enzyme is not available in its monomeric or catalytically activ
240 ing to political and regulatory barriers, it is not available in many settings around the world, whic
247 to distinguish clinically, and rapid testing was not available in many Ebola Treatment Units (ETUs),
248 tion increased cocaine seeking when the drug was not available in rats trained to discriminate its pr
250 ligible studies; if the required information was not available in the published report, we requested
254 as where electrophysiology subspecialty care is not available leads to outcomes that are noninferior
256 -SCID for whom an HLA-identical family donor was not available; most were not responding well to ERT.
258 are unknown and antemortem diagnostic tests are not available, neuropathology studies suggest a path
259 specific triggers of manic symptoms, studies are not available on the effectiveness of targeted inter
260 onary information, however, that information is not available on the level of a single sequence.
261 e added valuable prognostic information that was not available on standard preoperative testing.
264 onor/HLA-matched family donor HSCT or HSC-GT are not available or have failed, ERT can be continued o
265 viral therapy, especially when fecal samples are not available or molecular diagnostic tests are not
266 onitoring where reference-standard equipment is not available or feasible, and that they may be usefu
267 ing arbitrary numbers of hybrid layers which are not available otherwise, because epitaxial strain is
269 ources of cancer cell lines to perturbations are not available, resulting in a critical knowledge gap
272 anges where stable, transform-limited pulses are not available, such as X-ray free-electron lasers wh
273 Where spaceflight-specific data/equations were not available, terrestrial data/equations were used
274 most candidates when recombination map data are not available, the [Formula: see text] and [Formula:
276 ical equations describing a physical process is not available, the new approach can significantly acc
277 y control at the liquid/solid interface that is not available through conventional CVD synthesis at t
278 a and the possibility that complete continua were not available through our comprehensive search of t
279 ased lifetime-risk data for implant revision are not available to aid patient decision making, which
280 f quality performance and outcome indicators are not available to guide patient choice, these policie
281 ionary pathway to extremes in body size that are not available to lineages that must feed on one prey
282 or the high volume of sequence homologs that are not available to most of the non-humongous protein t
285 us enzymes or deletion of competing pathways are not available to the metabolic engineer; instead, fa
287 settings with sophisticated intensive care, is not available to infants in many sub-Saharan African
288 a suitable questionnaire in German language is not available to monitor the progression and evaluate
289 ement for rheumatic mitral regurgitation but is not available to the vast majority of patients in end
291 geographically independent cohorts(7,8) that were not available to us when we trained the algorithms.
295 pplication runs even when a native structure is not available, visualizing the contact coverage and s
298 evealed many details of retinal disease that were not available with older imaging technologies.